Perceptive Advisors

Top Portfolio
Top Buys
Top Sells
New Buys
Exits
Verona Pharma plc
VRNA
$60.52M37.113.76M-2.71%-$1.68M0.04
Lyra Therapeutics, Inc.
LYRA
$79.35M20.9312.76M0%+$00.05
Solid Biosciences Inc.
SLDB
$92M186.91M+97.56%+$45.43M0.06
MeiraGTx Holdings plc
MGTX
$68.72M17.6211.33M0%+$00.05
Verrica Pharmaceuticals Inc.
VRCA
$42.03M16.747.1M0%+$00.03
Astria Therapeutics, Inc.
ATXS
$91.25M11.816.49M+61.97%+$34.91M0.06
Nautilus Biotechnology, Inc.
NAUT
$37.03M10.0512.59M0%+$00.02
Amicus Therapeutics, Inc.
FOLD
$330.52M9.4728.06M0%+$00.21
Evolus, Inc.
EOLS
$80.55M9.195.75M+45.17%+$25.07M0.05
Soleno Therapeutics, Inc.
SLNO
$131.59M8.873.07M0%+$00.09
CARGO Therapeutics, Inc. Common Stock
CRGX
$76.96M8.763.45M+0.33%+$254,537.280.05
Fusion Pharmaceuticals Inc.
FUSN
$145.52M8.026.83M+148.07%+$86.86M0.09
Celcuity Inc.
CELC
$51.03M7.562.36M+59.47%+$19.03M0.03
Arcellx, Inc.
ACLX
$273.58M7.353.93M-13.45%-$42.51M0.18
Applied Therapeutics, Inc.
APLT
$54.43M7.018.01M+96.19%+$26.69M0.04
Iovance Biotherapeutics, Inc.
IOVA
$285.63M6.8919.27M+60.88%+$108.09M0.19
Artivion, Inc.
AORT
$56.48M6.42.67M+186.57%+$36.77M0.04
Spyre Therapeutics, Inc.
SYRE
$96.97M6.352.56M-1.92%-$1.9M0.06
Cerevel Therapeutics Holdings, Inc.
CERE
$456.3M5.9310.79M-1.55%-$7.2M0.3
Viridian Therapeutics, Inc.
VRDN
$64.04M5.733.66M+111.37%+$33.74M0.04
Rhythm Pharmaceuticals, Inc.
RYTM
$141.63M5.363.27M+51.74%+$48.29M0.09
Praxis Precision Medicines, Inc.
PRAX
$50.13M4.8821,589New+$50.13M0.03
Apogee Therapeutics, Inc.
APGE
$179.37M4.622.7M+47.67%+$57.91M0.12
Immatics N.V.
IMTX
$48.16M4.454.58M+31.25%+$11.47M0.03
Nuvalent, Inc.
NUVL
$209.01M4.312.78M-4.61%-$10.1M0.14
Disc Medicine, Inc.
IRON
$58.52M3.8939,866-8.13%-$5.18M0.04
Tarsus Pharmaceuticals, Inc.
TARS
$47.12M3.431.3M0%+$00.03
SpringWorks Therapeutics, Inc.
SWTX
$111.36M3.052.26M+15.59%+$15.02M0.07
ADMA Biologics, Inc.
ADMA
$42.46M2.786.43M0%+$00.03
Edgewise Therapeutics, Inc.
EWTX
$42.31M2.482.32M+317.54%+$32.18M0.03
Axsome Therapeutics, Inc.
AXSM
$88.21M2.331.11M+6.49%+$5.37M0.06
Immunovant, Inc.
IMVT
$95.74M2.032.96M+27.28%+$20.52M0.06
Madrigal Pharmaceuticals, Inc.
MDGL
$114.81M2.02429,953+184.45%+$74.45M0.07
Akero Therapeutics, Inc.
AKRO
$35.05M2.011.39M+43.37%+$10.6M0.02
Rocket Pharmaceuticals, Inc.
RCKT
$48.52M1.981.8M+5.49%+$2.52M0.03
CG Oncology, Inc. Common stock
CGON
$57.25M1.961.3MNew+$57.25M0.04
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$94.34M1.951.73M0%+$00.06
Crinetics Pharmaceuticals, Inc.
CRNX
$69.1M1.871.48M+17.58%+$10.33M0.05
Arvinas, Inc.
ARVN
$51.05M1.811.24M+249.24%+$36.43M0.03
Vaxcyte, Inc.
PCVX
$132.03M1.781.93M+77.56%+$57.67M0.09
Xenon Pharmaceuticals Inc.
XENE
$38.41M1.18892,208-18.95%-$8.98M0.03
Intra-Cellular Therapies, Inc.
ITCI
$73.03M11.06M+877.18%+$65.56M0.05
Viking Therapeutics, Inc.
VKTX
$81.52M0.9994,098New+$81.52M0.05
Neurocrine Biosciences, Inc.
NBIX
$110.94M0.8804,409+197.06%+$73.6M0.07
BridgeBio Pharma, Inc.
BBIO
$43.66M0.761.41M-19.26%-$10.42M0.03
Natera, Inc.
NTRA
$69.26M0.62757,225-10.94%-$8.51M0.05
Sarepta Therapeutics, Inc.
SRPT
$68.05M0.56525,683+16.33%+$9.56M0.04
Medtronic plc
MDT
$124.59M0.111.43M+46.37%+$39.47M0.08
Intuitive Surgical, Inc.
ISRG
$40.63M0.03101,800+85.09%+$18.68M0.03
Inhibrx, Inc.
INBX
$148.79B<0.014.26M0%+$096.43